Xspray Pharma AB (publ)

OM:XSPRAY Stock Report

Market Cap: SEK 1.6b

Xspray Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:XSPRAY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Jul 24BuySEK 5,561,508Flerie AB (publ)Company111,276SEK 49.98
29 Jul 24BuySEK 4,791,953Anders BladhIndividual104,776SEK 45.82
03 Jul 24BuySEK 142,770Anders BladhIndividual1,790SEK 79.76
04 Jun 24BuySEK 145,656Ribbskottet ABCompany1,958SEK 74.39
03 Jun 24BuySEK 225,078Anders BladhIndividual3,042SEK 73.99
31 May 24BuySEK 342,650Ribbskottet ABCompany5,000SEK 68.53
27 May 24BuySEK 690,000Anders BladhIndividual10,000SEK 69.00
27 May 24SellSEK 687,545Per AnderssonIndividual9,950SEK 69.10
24 May 24BuySEK 97,878Anders BladhIndividual1,668SEK 58.68
21 May 24BuySEK 564,600Anders BladhIndividual10,000SEK 56.46
16 May 24BuySEK 503,500Anders BladhIndividual10,000SEK 50.35
17 Jan 24BuySEK 2,115,507Anders BladhIndividual60,000SEK 35.47

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of XSPRAY?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,313,3566.23%
Private Companies3,829,16310.3%
VC/PE Firms5,332,84214.4%
General Public12,609,06534%
Institutions13,054,06535.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.8%.

Top Shareholders

Top 25 shareholders own 66.02% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.4%
Flerie AB (publ)
5,332,842SEK 229.3m2.13%33.51%
10.3%
Ribbskottet AB
3,829,163SEK 164.7m0%no data
10%
Östersjöstiftelsen, Endowment Arm
3,717,626SEK 159.9m0%14.38%
8.41%
Fourth Swedish National Pension Fund (AP4)
3,122,228SEK 134.3m0%0.05%
3.33%
Unionen, Endowment Arm
1,237,749SEK 53.2m0%1.44%
3.14%
Tredje AP-fonden
1,166,666SEK 50.2m0%0.02%
3.01%
Nordnet AB (publ), Asset Management Arm
1,117,619SEK 48.1m0%0.66%
2.73%
Avanza Fonder AB
1,012,829SEK 43.6m0%0.05%
2.51%
Andra AP-fonden
933,480SEK 40.1m0%0.02%
2.27%
Anders Bladh
841,735SEK 36.2m14.5%no data
1.64%
Carl Norman
609,913SEK 26.2m0%no data
1.55%
Anders Ekblom
577,396SEK 24.8m0%no data
0.52%
Per Andersson
194,060SEK 8.3m0%no data
0.5%
C WorldWide Asset Management Fondsmaeglerselskab A/S
186,200SEK 8.0m0%0.01%
0.46%
Handelsbanken Asset Management
170,516SEK 7.3m0%no data
0.41%
SEB Investment Management AB
153,716SEK 6.6m0%no data
0.27%
FCG Fonder AB
101,745SEK 4.4m0%0.05%
0.2%
Cicero Fonder AB
75,689SEK 3.3m0%0.06%
0.083%
Maris Hartmanis
31,004SEK 1.3m0%no data
0.081%
Christer Hallgren
29,996SEK 1.3m0%no data
0.058%
Dimensional Fund Advisors LP
21,606SEK 929.1k12.2%no data
0.05%
Skandia Fonder AB
18,482SEK 794.8k0%no data
0.048%
Storebrand Fonder AB,
17,914SEK 770.4k0%no data
0.027%
Robert Molander
10,000SEK 430.1k0%no data
0.022%
Kerstin Hasselgren
8,248SEK 354.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 11:26
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Xspray Pharma AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dan AkschutiPareto Securities
Filip EinarssonRedeye